EYEGATE PHARMACEUTICALS INC's ticker is EYEG and the CUSIP is 30233M107. A total of 20 filers reported holding EYEGATE PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $4,000 | -20.0% | 16,000 | 0.0% | 0.00% | -100.0% |
| Q1 2019 | $5,000 | -44.4% | 16,000 | -20.0% | 0.00% | 0.0% |
| Q4 2018 | $9,000 | +50.0% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $6,000 | -45.5% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $11,000 | +37.5% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $8,000 | -61.9% | 20,000 | 0.0% | 0.00% | -66.7% |
| Q4 2017 | $21,000 | – | 20,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 1,192,000 | $453,000 | 0.04% |
| IFP Advisors, Inc | 23,800 | $25,000 | 0.00% |
| Holistic Financial Partners | 1,900 | $1,000 | 0.00% |
| Vantage Investment Advisors, LLC | 6,500 | $2,000 | 0.00% |
| WEDBUSH SECURITIES INC | 20,000 | $8,000 | 0.00% |
| US BANCORP \DE\ | 40,650 | $15,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 100 | $0 | 0.00% |
| NORTHERN TRUST CORP | 14,553 | $6,000 | 0.00% |
| CREDIT SUISSE AG/ | 26,500 | $10,000 | 0.00% |
| MORGAN STANLEY | 7,721 | $3,000 | 0.00% |